Form 4: STAAR Surgical CFO Patrick F. Williams Reports Stock Transactions
SEC Form 4
Patrick F. Williams, CFO of STAAR Surgical, reports the vesting of performance stock units and restricted stock units.
Summary
- Patrick F. Williams, the Chief Financial Officer of STAAR Surgical Co, filed a Form 4 detailing changes in beneficial ownership.
- The transactions involve the vesting of performance stock units (PSUs) and restricted stock units (RSUs).
- On March 7, 2025, 2,614 PSUs vested, representing 1/3 of the PSUs granted on March 7, 2022.
- Also on March 7, 2025, 3,075 RSUs vested, representing 1/3 of the RSUs granted on March 7, 2022.
- On March 10, 2025, 4,061 RSUs vested, representing 1/3 of the RSUs granted on March 10, 2023.
- Following these transactions, Williams directly owns 48,089 shares of common stock and 4,062 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock vesting, so it doesn't inherently indicate positive or negative sentiment. It reflects standard compensation practices.
Positives
- The vesting of stock units indicates that the company is meeting pre-established financial metrics, at least to the extent required for the PSUs to vest.
Future Outlook
The document indicates that some RSUs are subject to future vesting, with the remaining 1/3 of the RSUs granted on March 10, 2023, vesting on March 10, 2026.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and alignment with shareholder interests.
Comparison to Industry Standards
- Stock-based compensation is a common practice in the medical device industry to incentivize executives and align their interests with those of shareholders.
- Companies like Alcon, Johnson & Johnson (DePuy Synthes), and Medtronic also utilize stock options and restricted stock units as part of their executive compensation packages.
- The vesting schedules and amounts are generally comparable to industry standards for CFO-level executives.
Stakeholder Impact
- The vesting of stock units dilutes existing shareholders' equity to a small degree.
- It incentivizes the CFO to continue working towards the company's success, which benefits shareholders in the long run.
Key Dates
| Date | Description |
|---|---|
| 03/07/2022 | Date of original grant for PSUs and RSUs vesting on March 7, 2025 |
| 03/10/2023 | Date of original grant for RSUs vesting on March 10, 2025 |
| 03/07/2025 | Vesting date for 2,614 PSUs and 3,075 RSUs |
| 03/10/2025 | Vesting date for 4,061 RSUs |
| 03/11/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.